InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
InnovAge Holding Corp.NASDAQ: INNV
Stock-Based Compensation · Q3 FY2026 · quarter ended Mar 2026
Stock-based compensation outflow shrinks to $0
Q3 FY2026 stock-based compensation was $0, compared with $2.03M a year earlier. Trailing-twelve-month stock-based compensation was $3.36M. Over 3 fiscal years it compounded at +26.8% a year.
Context
- Stock-based compensation amounted to 0.9% of revenue in FY2025, unchanged from a year earlier.
- Stock-based compensation increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $841K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 7.62M USD
- Year-over-year change
- +11.5%
- 4-year CAGR
- -36.6%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 7.62M | +11.5% |
| FY2024 | 2024-06-30 | 6.83M | +0.0% |
| FY2023 | 2023-06-30 | 6.83M | +82.7% |
| FY2022 | 2022-06-30 | 3.74M | -92.1% |
| FY2021 | 2021-06-30 | 47.05M | — |
Stock-Based Compensation vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 stock-based compensation of $3.36M is the smallest of the 8 companies compared; the peer median is $13.63M.
- Its year-over-year change of -56.6% is the 7th highest of 8, against a peer median of +35.8%.
- Stock-based compensation amounts to 0.4% of revenue for INNV, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $55.97M | +35.2% | +28.6% | 1.0% | |
| LTM Sep 2026 | $51.51M | +289.2% | -6.2% | 1.7% | |
| LTM Jun 2026 | $23.22M | +74.9% | +15.6% | 1.6% | |
| LTM Oct 2026 | $16.97M | -165.0% | — | 0.6% | |
| LTM Mar 2026 | $13.63M | +60.6% | +42.6% | 1.3% | |
| LTM Mar 2026 | $6.47M | +35.8% | +5.3% | 1.6% | |
| LTM Sep 2026 | $6.19M | +34.5% | +19.0% | 0.4% | |
| LTM Mar 2026 | $3.36M | -56.6% | +26.8% | 0.4% | |
| Peer median (excluding INNV) | $13.63M | +35.8% | +17.3% | 1.3% | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (43.99M) | (6.52M) | (23.22M) | (23.22M) | (35.34M) |
| Depreciation & Amortization | 13.35M | 14.35M | 18.95M | 18.95M | 19.51M |
| Deferred Income Tax | 0 | 0 | 1.22M | 1.22M | 1.3M |
| Stock-Based Compensation | 47.05M | 3.74M | 6.83M | 6.83M | 7.62M |
| Change in Working Capital | (2.59M) | (7.4M) | (52.15M) | (52.15M) | 15.24M |
| Accounts Receivables | 5.88M | (9.51M) | (33.4M) | (30.33M) | 11.22M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 1.37M | 1.37M | 20.43M |
| Other Working Capital | (8.47M) | 2.11M | (20.12M) | (23.18M) | (16.42M) |
| Other Non-Cash Items | (21.37M) | 23.13M | 11.46M | 11.46M | 24.54M |
| Operating Cash Flow | (7.55M) | 27.3M | (36.9M) | (36.9M) | 32.87M |
| Capital Expenditures | (17.54M) | (38.24M) | (7.91M) | (7.91M) | (6.26M) |
| Acquisitions (Net) | 0 | 0 | (19.07M) | (19.07M) | (3.52M) |
| Purchases of Investments | 0 | 0 | (2.39M) | (2.39M) | (2.07M) |
| Sales of Investments | 0 | 0 | 3M | 3M | 6.3M |
| Other Investing Activities | (2M) | (2M) | 0 | 0 | 0 |
| Investing Cash Flow | (19.54M) | (40.24M) | (26.37M) | (26.37M) | (5.55M) |
| Debt Repayment | (139.45M) | (6.32M) | (8.43M) | (8.43M) | (9.91M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (77.6M) | 0 | (179K) | (179K) | (7.32M) |
| Dividends Paid | (9.5M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 342.78M | 0 | 1.58M | 1.58M | (1.86M) |
| Financing Cash Flow | 116.22M | (6.32M) | (7.03M) | (7.03M) | (19.08M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 89.14M | (19.25M) | (70.31M) | (70.31M) | 8.23M |
| Free Cash Flow | (25.09M) | (10.94M) | (44.81M) | (44.81M) | 26.6M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.